Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.79.5.7962320PMID 7962320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diurnal Variation in Glucose Tolerance: Cyclic Suppression of Insulin Action and Insulin Secretion in Normal-Weight, But Not Obese, Subjects

  1992cited by this paper
• Insulin resistance, secretion, and metabolism in users of oral contraceptives.

  1992cited by this paper
• The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

  1990cited by this paper
• Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.

  1990cited by this paper
• Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.

  1990cited by this paper
• Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach

  1989cited by this paper
• Carbohydrate metabolic studies during twelve months of treatment with a low-dose combination oral contraceptive.

  1989cited by this paper
• Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

  1988cited by this paper
• Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents.

  1988cited by this paper
• Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.

  1987cited by this paper
• Modified protocols improve insulin sensitivity estimation using the minimal model.

  1987cited by this paper
• Impaired glucose tolerance in women using oral contraceptives: United States, 1976-1980.

  1987cited by this paper
• Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

  1984cited by this paper
• Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

  1981cited by this paper
• Quantitative Estimation of Beta Cell Sensitivity to Glucose in the Intact Organism: A Minimal Model of Insulin Kinetics in the Dog

  1980cited by this paper
• Quantitative estimation of insulin sensitivity.

  1979cited by this paper
• Neonatal necrotizing enterocolitis.

  1969cited by this paper
• Coated charcoal immunoassay of insulin.

  1965cited by this paper
• Intravenous Glucose Tolerance as a Tool in Definition and Diagnosis of Diabetes Mellitus*

  1962cited by this paper

• The main directions and prospects in polycystic ovary syndrome treatment

  2021cites this paper
• EFFECT OF CHLORMADINONE-CONTAINING CONTRACEPTIVES ON CARBOHYDRATE AND LIPID METABOLISM IN WOMEN WITH METABOLIC SYNDROME

  2021cites this paper
• Ethinyl Estradiol vs Estradiol Valerate in Combined Oral Contraceptives - Effect on Glucose Tolerance: A Randomized, Controlled Clinical Trial.

  2020cites this paper
• Polycystic Ovary Syndrome and Metabolic Syndrome

  2019cites this paper
• Lipid profile and cardiovascular risk indices of women on various types of contraceptives in the Ho Municipality of Ghana

  2018cites this paper
• Menarcheal Age and Risk of Type 2 Diabetes: A Community-Based Cohort Study

  2017cites this paper
• Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome

  2016cites this paper
• The impact of oral contraceptives on cardiometabolic parameters

  2016cites this paper
• Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome

  2016cites this paper
• Estrogen Metabolite 16&agr;-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism

  2016cites this paper
• Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits.

  2016cites this paper
• The Estrogen Metabolite 16 OHE Exacerbates BMPR 2-Associated PAH Through miR-29-Mediated Modulation of Cellular Metabolism

  2015cites this paper
• Polycystic ovary syndrome: current status and future perspective.

  2014cites this paper
• The Effects of Hormonal Contraceptives on Glycemic Regulation

  2014cites this paper
• THE ASSOCIATION BETWEEN DURATION OF ORAL CONTRACEPTIVE PILLS CONSUMPTION WITH METABOLIC SYNDROME: TEHRAN LIPID AND GLUCOSE STUDY

  2014cites this paper
• Cardiovascular risk in young women with Polycystic OvarySyndrome

  2014cites this paper
• Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community

  2014cites this paper
• Oral contraceptive use and measurable cardiovascular risk factors in Korean women aged 20–50 years: The Fourth Korean National Health and Nutrition Examination Survey 2007–2009 (KNHANES IV)

  2013cites this paper
• Sex hormone binding globulin and insulin resistance

  2013cites this paper
• Strengths and Weaknesses of the Main Features of PCOS as Adapted from the NIH Evidence-Based Methodology Workshop on PCOS

  2013cites this paper
• Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

  2013cites this paper
• Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.

  2012cites this paper
• Dietary Factors, Biomarkers and Type 2 Diabetes Risk in Postmenopausal Women: An Investigation of the Biologic Pathway for Reduced Diabetes Risk by Diet

  2012cites this paper
• Combined estrogen-progestogen but not progestogen-only oral contraceptive alters glucose tolerance and plasma lipid profile in female rats.

  2012cites this paper
• Effect of Combined Oral Contraceptives on Insulin Clearance in Lean and Obese Pre-menopausal Women

  2011cites this paper
• The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.

  2011cites this paper
• Effects of Insulin Sensitivity Modulators on the Mitochondrial Fate of Oxygen in Skeletal Muscle

  2010cites this paper
• Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999–2004

  2009cites this paper
• L'assunzione di associazioni estro-progestiniche seleziona due popolazioni femminili che differiscono in molti aspetti inclusi i processi di metilazione del DNA

  2009cites this paper
• Effect of low-dose oral contraceptives on metabolic risk factors in African-American women.

  2008influential citation
• Polycystic Ovary Syndrome and Metabolic Syndrome

  2008cites this paper
• Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment

  2008cites this paper
• Effect of a new oral contraceptive with drospirenone on vital signs, complete blood count, glucose, electrolytes, renal, and liver function.

  2007cites this paper
• Chronic Treatment of Polycystic Ovary Syndrome

  2007cites this paper
• Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive.

  2007cites this paper
• Combined oral contraceptives in the treatment of polycystic ovary syndrome.

  2005influential citation
• Oestrogens and insulin secretion

  2005cites this paper
• Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

  2005cites this paper
• A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

  2005cites this paper
• Serum leptin concentration and anaerobic performance do not change during the menstrual cycle of young females.

  2005cites this paper
• Effects of oral contraceptives on glucoregulatory responses to exercise.

  2004cites this paper
• Pharmacological Agents That Directly Modulate Insulin Secretion

  2003cites this paper
• A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.

  2003cites this paper
• Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences

  2002cites this paper
• Effects of oral contraceptives with low-dose estrogen and desogestrel on leptin concentrations.

  2002cites this paper
• Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.

  2002cites this paper
• Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.

  2002cites this paper
• Effects of pregnancy on insulin receptor in liver, skeletal muscle and adipose tissue of rats

  2002cites this paper
• Role of 17β-estradiol administration on insulin sensitivity in the rat: implications for the insulin receptor

  2002cites this paper
• An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.

  2002cites this paper
• Effect of treatment with different doses of 17-beta-estradiol on insulin receptor substrate-1.

  2001cites this paper
• Role of 17beta-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy.

  2000cites this paper
• Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

  2000cites this paper
• Hormonal Response to Exercise

  2000cites this paper
• Occlusive Vascular Diseases in Oral Contraceptive Users

  2000cites this paper
• Modification of plasma insulin-like growth factors and binding proteins during oral contraceptive use and the normal menstrual cycle.

  1999cites this paper
• The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment

  1999cites this paper
• Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.

  1999cites this paper
• Leptin and reproduction: is it a critical link between adipose tissue, nutrition, and reproduction?

  1999cites this paper
• Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.

  1998cites this paper
• [Hormonal contraception in the diabetic woman].

  1998cites this paper
• Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism.

  1998cites this paper
• The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.

  1997cites this paper
• Oral Contraception and Adolescent Women With Insulin-Dependent Diabetes Mellitus: Risks, Benefits, and Implications for Practice

  1996cites this paper
• Role of Glucose Effectiveness in the Determination of Glucose Tolerance

  1996cites this paper
• The influence of female sex steroids on glucose metabolism and insulin action.

  1996cites this paper
• Factors Associated With Glucose and Insulin Levels in Healthy Postmenopausal Women

  1996cites this paper
• Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes

  1995cites this paper
• Oral contraceptive side effects: where's the beef?

  1995cites this paper
• effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a ghanaian community

  year unknowncites this paper